GÖRG advised Applyo Jena GmbH under the lead of Hamburg partner Prof Dr Stephan R. Göthel on a Series A financing round. Bosch Ventures is investing as lead investor together with LBBW Venture Capital in the international expansion of the diagnostics business and market entry into the pharmaceutical industry. 

Applyo Jena convinced Bosch Ventures, a corporate venture capital company of the Bosch Group, and LBBW Venture Capital with its innovative freeze-drying technology and successfully concluded the financing round.

The biotechnology company has developed a proprietary freeze-drying process that offers advantages over conventional liquid reagents, which require refrigeration. Its unique feature lies in the precise, highly scalable production of ‘Lyo-Beads’ in homogeneous quality. Among other things, this technology enables storage and transport without a continuous cold chain and contributes to the sustainable optimisation of supply chains.

The company, which was founded in 2021, plans to use the new investment funds to drive forward its internationalisation, expand the diagnostics business and enter the pharmaceutical market. 

GÖRG advised Applyo Jena on all legal matters in the financing round. 

The lead partner, Prof Dr Stephan R. Göthel, advises companies from a wide range of sectors, from start-ups to market leaders, as well as investors in the areas of M&A, private equity/venture capital and corporate law. Stephan R. Göthel has extensive experience in national and international mergers and acquisitions, joint ventures, corporate finance and management and employee participation programs.

Advisors Applyo Jena GmbH

GÖRG Partnerschaft von Rechtsanwälten mbB 
Prof Dr Stephan R. Göthel, LL.M. (Cornell) (Lead, Partner, Venture Capital, Hamburg)
Felix Schmidt (Associate, Venture Capital, Hamburg)